Do Asian patients have worse lupus?

Lupus

Volumn 19, Issue 12, 2010, Pages 1384-1390

  Mok, M Y ^a   Li, W L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

damage index; mortality; systemic lupus erythematosus

Indexed keywords

CD16 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DOUBLE STRANDED DNA ANTIBODY; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR IIIA; FC RECEPTOR IIIB; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; RO ANTIBODY; SM ANTIBODY; TNFAIP3 PROTEIN; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AFRICAN CARIBBEAN; ALLELE; ASIAN; BEHAVIOR; BINDING AFFINITY; CAUCASIAN; CULTURAL ANTHROPOLOGY; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE MAP; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL DISEASE; MORTALITY; OUTCOME ASSESSMENT; PATIENT EDUCATION; POVERTY; PREDICTION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RACE DIFFERENCE; REVIEW; SCORING SYSTEM; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SURVIVAL RATE;

EID: 78649748430     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310375832     Document Type: Review

References (50)

1. Danchenko N., Satia JA, Anthony MS Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006 ; 15: 308-318.
2. Frank AO Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia. Ann Rheum Dis 1980 ; 39: 266-269.
3. Wang F., Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997 ; 6: 248-253.
4. Serdula MK, Rhoads GG Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979 ; 22: 328-333.
5. Hopkinson ND, Doherty M., Powell RJ Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994 ; 53: 675-680.
6. Kaslow RA High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum 1982 ; 25: 414-418.
7. Johnson SR, Urowitz MB, Ibanez D., Gladman DD Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol 2006 ; 33: 1990-1995.
8. Ward MM Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 2004 ; 51: 616-624.
9. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 47-56.
10. Ramos PS, Brown EE, Kimberly RP, Langefeld CD Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol 2010 ; 30: 164-176.
11. Freedman BI, Wilson CH, Spray BJ, Tuttle AB, Olorenshaw IM, Kammer GM Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis 1997 ; 29: 729-732.
12. Quintero-Del-Rio AI, Kelly JA, Kilpatrick J., James JA, Harley JB The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3) Genes Immun 2002 ; 3 (Suppl 1). S57-62.
13. Morel L. Genetics of human lupus nephritis. Semin Nephrol 2007 ; 27: 2-11.
14. Li LH, Yuan H., Pan HF, Li WX, Li XP, Ye DQ Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Scand J Rheumatol 39: 148-154.
15. Lee YH, Ji JD, Song GG Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Lupus 2009 ; 18: 727-734.
16. Yuan H., Pan HF, Li LH, et al. Meta-analysis on the association between FcgammaRIIa-R/H131 polymorphisms and systemic lupus erythematosus. Mol Biol Rep 2009 ; 36: 1053-1058.
17. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG Functional monocyte chemoattractant protein-1 promoter -2518 polymorphism and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2009 ; [Epub ahead of print].
18. Touyz RM Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005 ; 7: 1302-1314.
19. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG Angiotensin-converting enzyme insertion/deletion polymorphism and systemic lupus erythematosus: a meta-analysis. J Rheumatol 2006 ; 33: 698-702.
20. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 2009 ; 18: 9-15.
21. Bates JS, Lessard CJ, Leon JM, et al. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun 2009 ; 10: 470-477.
22. Gladman DD Prognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol 1991 ; 3: 789-796.
23. Ward MM, Pyun E., Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996 ; 156: 1337-1344.
24. Lau CS, Yin G., Mok MY Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 2006 ; 15: 715-719.
25. Korbet SM, Schwartz MM, Evans J., Lewis EJ Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007 ; 18: 244-254.
26. Peschken CA, Katz SJ, Silverman E., et al. The 1000 Canadian faces of lupus: determinants of disease outcome in a large multi-ethnic cohort. J Rheumatol 2009 ; 36: 1200-1208.
27. Boey ML, Peebles CL, Tsay G., Feng PH, Tan EM Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988 ; 47: 918-923.
28. Lee SS, Li CS, Li PC Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993 ; 2: 105-109.
29. Cervera R., Font J., Shoenfeld Y. European Working Party on Systemic Lupus Erythematosus: a 15-year report. Autoimmun Rev 2006 ; 5: 549-553.
30. Bastian HM, Roseman JM, McGwin Jr G., et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002 ; 11: 152-160.
31. Petri M. Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort. Lupus 2005 ; 14: 970-973.
32. Samanta A., Feehally J., Roy S., Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991 ; 50: 490-492.
33. Thumboo J., Uramoto K., O'Fallon WM, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 2001 ; 45: 494-500.
34. Patel M., Clarke AM, Bruce IN, Symmons DP The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheum 2006 ; 54: 2963-2969.
35. Shayakul C., Ong-aj-yooth L., Chirawong P., et al. Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis 1995 ; 26: 300-307.
36. Lee HS, Spargo BH A renal biopsy study of lupus nephropathy in the United States and Korea. Am J Kidney Dis 1985 ; 5: 242-250.
37. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369.
38. Nived O., Jonsen A., Bengtsson AA, Bengtsson C., Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol 2002 ; 29: 1398-1400.
39. Stoll T., Seifert B., Isenberg DA SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996 ; 35: 248-254.
40. Alarcon GS, McGwin Jr G., Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001 ; 44: 2797-2806.
41. Mok CC, Ho CT, Wong RW, Lau CS Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003 ; 30: 1513-1519.
42. Maskarinec G., Katz AR Prevalence of systemic lupus erythematosus in Hawaii: is there a difference between ethnic groups? Hawaii Med J 1995 ; 54: 406-409.
43. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000 ; 39: 399-406.
44. Gladman DD Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1995 ; 7: 402-408.
45. Kumar A., Malaviya AN, Singh RR, Singh YN, Adya CM, Kakkar R. Survival in patients with systemic lupus erythematosus in India. Rheumatol Int 1992 ; 12: 107-109.
46. Walsh SJ, DeChello LM Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 2001 ; 10: 637-646.
47. Barr RG, Seliger S., Appel GB, et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 2003 ; 18: 2039-2046.
48. Karlson EW, Daltroy LH, Lew RA, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995 ; 38: 267-273.
49. Sutcliffe N., Clarke AE, Gordon C., Farewell V., Isenberg DA The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999 ; 38: 1130-1137.
50. Bae SC, Hashimoto H., Karlson EW, Liang MH, Daltroy LH Variable effects of social support by race, economic status disease activity in systemic lupus erythematosus. J Rheumatol 2001 ; 28: 1245-1251.